Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...
Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, whi...
Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is r...
Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) ...
Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Ch...
Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Healt...
Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for...
Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the mi...
Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, ...
Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustai...
Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cance...
Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]...
Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials scie...
Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...
Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prize...
Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...
Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dr...
